Dr. Sanjay Gupta

It is a peptide.

Insulin is a peptide.

These are peptides.

I don't know how much you think about this aspect of things, but there's a lot of other peptides that people are talking about in the wellness community.

And friends of mine who say, yeah, I'm definitely taking these now.

It helps me.

They're injecting themselves with these peptides.

Have you learned anything about these?

I mean, one of these people who I'm talking about, one of my friends said, oh, yeah, I had a really bad reaction to taking it.

They had to keep me in the office a lot longer, take my blood pressure.

I felt very faint, like I was going to pass out.

And I'm thinking, isn't this part of the problem?

You know, like there can be significant side effects.

And a lot of times they're taking these in non-medical settings, potentially really problematic.

At the same time, though, when it comes to GLP drugs, a lot of the testing has been done on very specific patient populations.

patients who have diabetes, patients who have obesity.

But I think what we see is that a lot of people are taking these off label or not for the specific, you know, indications.

So how do you think about that and what does that mean in terms of safety?

Because we don't have safety data on all the populations, like someone who's just taking it to lose a few pounds, which I hear a lot of.

How do you sort of frame that conversation for people?